Alkermes logo

Alkermes

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Headshot of a person smiling

Diversity & Inclusion | Alkermes

Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes

Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive our innovation, and their passion and commitment to excellence are the cornerstone of our success.

Flexible Media Releases

Alkermes Survey Explores Impact of Bipolar I Disorder Medication Side Effects

For Individuals With Bipolar 1 Disorder Finding the Right Treatment Can Be a Long and Difficult Process

Black History Month and Mental Health

Results From The Harris Poll and Depression and Bipolar Support Alliance

Alkermes Educates on the Challenges of Mucosal Melanoma

Alkermes Highlights Signs and Symptoms of Schizophrenia

New National Survey of People Living With Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey

Alkermes Highlights Ongoing Investigational Immuno-oncology Clinical Trials

Alkermes' Senior VP, Human Resources Celebrates Its Unique Culture

Alkermes Spotlights Cancer Research

Alkermes Has Launched Employee Resource Groups

Our Collective Responsibility to Respond Effectively to the Climate Crisis

Alkermes in Action: Giving Tuesday

One Overdose Is Too Many

Alkermes Celebrates National Family Caregivers Month

Campaigns

Alkermes: Corporate Responsibility
We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...

Alkermes: Diversity, Inclusion & Belonging
Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...

Alkermes Medicines & Focus: Serious Mental Illness
We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...

Alkermes Medicines & Focus: Cancer
We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...

Alkermes Inspiration Grants®
Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive...

Alkermes Medicines & Focus: Addiction
We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...

Videos

Contact Alkermes
open_in_new
Alkermes